Two-Dimensional Atrial Systolic Strain Imaging Predicts Atrial Fibrillation at 4-Year Follow-Up in Asymptomatic Rheumatic Mitral Stenosis




Background


The aim of this study was to assess systolic left atrial (LA) reservoir function in patients with mitral stenosis (MS) using two-dimensional (2D) strain (ϵ) and strain rate imaging and its prognostic value in predicting atrial fibrillation (AF) at 4-year follow-up.


Methods


One hundred one asymptomatic patients with pure rheumatic MS and 70 healthy controls were evaluated using standard Doppler echocardiography (mitral valve area, mean gradient, systolic pulmonary pressure, LA width, LA volumes, and LA ejection fraction) and 2D speckle-tracking.


Results


LA width, volumes, and systolic pulmonary pressure were significantly increased ( P < .0001), and LA 2D ϵ and strain rate were significantly impaired in patients with MS ( P < .0001). At 4-year follow-up, 20 patients (20%) showed AF on standard electrocardiography or 24-hour Holter electrocardiography. Patients with MS who had AF were older than those who did not, without significant differences in LA dimensions, volumes, ejection fraction, and compliance index. Instead, atrial myocardial systolic 2D ϵ was significantly impaired in patients with events. On multivariate analysis (age, LA volume, planimetric mitral area, average annular Ea, and LA strain) the best predictor of AF was average LA peak systolic ϵ (coefficient, 0.43; SE, 0.098; P < .01), with an area under the receiver operating characteristic curve of 0.761 (SE, 0.085; 95% confidence interval, 0.587–0.888, P = .002) for a cutoff value of 17.4%.


Conclusions


The results of 2D ϵ imaging are abnormal in patients with asymptomatic MS and predict AF at 4-year follow-up.


Mitral stenosis (MS) is a progressive disease in which, after a stable course without symptoms, often the initial manifestation is the onset of atrial fibrillation (AF). Patients with MS are prone to develop AF; about 30% to 40% of patients with symptomatic MS develop AF. On the other hand, the onset of rapid AF in asymptomatic patients with severe MS can sometimes cause acute pulmonary edema, and this can be rapidly fatal; moreover, AF induces thromboembolic events, especially stroke, which make the prognosis worse. Although encouraging data have been obtained from previous studies demonstrating that Doppler strain rate (SR) imaging is able to assess early atrial reservoir dysfunction in patients with asymptomatic MS and to identify those patients at high risk for adverse events, the analysis has major drawbacks: angle dependence, reproducibility, and time-consuming acquisition and postprocessing. Recently, a new method, two-dimensional (2D) strain (ϵ) and SR imaging (speckle-tracking) has been developed to study ventricular function and has been used to evaluate atrial function. It is independent of both cardiac translation and angle dependency; it is based on an automated tracking system, with very good reproducibility, unlike Doppler-based ϵ imaging. Two-dimensional ϵ and SR imaging provides automatic calculation of mean values from the pattern of speckles in predefined myocardial segments, reflecting segmental function better than the analysis of only one point in space, used in previous Doppler ϵ analysis. The important advantage is that 2D ϵ uses 2D loops (grayscale images) from the routine echocardiographic examination, and it is becoming a widespread technique, with many clinical implications.


Thus far, there have been no studies based on speckle-tracking to assess atrial function in patients with MS. Thus, our aims were to assess the effect of pure rheumatic MS on left systolic atrial reservoir function, using speckle-tracking in asymptomatic patients with normal results on stress electrocardiography (ECG), and to evaluate the prognostic value of speckle-tracking in predicting the onset of AF at 4-year follow-up.


Methods


Patient Population


Among the 423 patients with MS followed at our institution, we enrolled 101 patients according to the following inclusion criteria: mild to moderate MS of rheumatic origin, sinus rhythm, recent (<2 months) negative results on exercise treadmill ECG at peak heart rate, and no need for medical therapy. According to American guidelines, MS was considered mild when the mean gradient was <5 mm Hg and valve area was >1.5 cm 2 and moderate when mean gradient was between 5 and 10 mm Hg and valve area was between 1 and 1.5 cm 2 .


Exclusion criteria were New York Heart Association class ≥II, diabetes mellitus, blood arterial hypertension, dyslipidemia, coronary artery disease, arrhythmias (according to history, ECG at inclusion, 24-hour Holter recording, and exercise treadmill ECG), associated valvular lesions such as more than mild aortic or mitral insufficiency, aortic stenosis, or more than mild tricuspid regurgitation, pulmonary arterial hypertension (≥45 mm Hg), left ventricular (LV) and right ventricular systolic dysfunction (LV ejection fraction [EF] <55%, right ventricular systolic annular velocity <11.5 cm/sec), LV hypertrophy (both septal and posterior wall thicknesses >11 mm), lung disease, and inadequate echocardiograms. One hundred one patients met these criteria and were included in the study.


As a reference group, we studied 70 healthy adult subjects, comparable for age and sex, without detectable cardiovascular disease and/or risk factors (family history of cardiac diseases, arterial hypertension, diabetes mellitus, hypercholesterolemia, cigarette smoking, and previous cerebrovascular disease) and without cardiovascular structural or functional abnormalities (normal results on clinical examination, ECG, and echocardiography) who were not receiving any medication.


Echocardiography


Standard Transthoracic Echocardiography


Complete mono and 2D color Doppler echocardiography was performed in each subject using the GE Vingmed System VII (GE Vingmed Ultrasound AS, Horten, Norway) with a 3.5-MHz variable-frequency harmonic phased-array transducer.


Left atrial (LA) width was measured during systole, in the long-axis view (anterior-posterior diameter) and in the four-chamber view (longitudinal and transverse diameters). The maximum and minimum LA volumes were calculated from apical four-chamber and apical two-chamber zoomed views of the left atrium, using the biplane method of disks.


The difference between maximum and minimum LA volume divided by minimum LA volume was used as index of atrial compliance.


LV global systolic function was evaluated by EF, using the biplane Simpson’s method. Right ventricular systolic function was evaluated using 2D fractional area change.


MS area was evaluated using 2D planimetry and the pressure half-time method, and the velocity-time integral of the mitral valve for mean transmitral gradient, according to guidelines. Pulmonary arterial pressure was estimated from tricuspid regurgitation, always adding 5 mm Hg. Three beats in each view were analyzed and averaged. Using Doppler tissue imaging, we measured early diastolic myocardial relaxation velocities (Ea) at the four areas of the mitral annulus and then calculated average annular Ea.


2D Strain


Two-dimensional ϵ uses grayscale (B-mode) sector images and is based on frame-by-frame tracking of small rectangular image blocks with stable speckle patterns. A minimum frame rate of 50 Hz was required for reliable operation of this program, and frame rates of 50 to 90 Hz were used for routine grayscale imaging. The apical four-chamber view was obtained using the same ultrasound system and probe used for standard echocardiography. By tracing the endocardial contour on an end-systolic cavitary frame after defining the thickness of the region to be considered, the software will automatically track the atrial wall on subsequent frames. Adequate tracking can be real-time verified and corrected by adjusting the region of interest or the contour (increased or decreased the width for thicker or thinner walls, respectively).


Using this technique, analysis was performed from the four-chamber and two-chamber apical views for the segments of LA septum, LA lateral wall, LA inferior wall, LA anterior wall, and near LA roof, as considered for Doppler ϵ imaging in previous studies, and then were averaged.


Accordingly, for each segment, during LV systole, LA wall longitudinal lengthening was represented with a peak positive ϵ value; it is observed because of filling of the atrial cavity by blood coming from the pulmonary veins while the mitral valve is closed. Myocardial longitudinal shortening was represented with a peak negative ϵ value; it occurs during LV diastole, when the atrium empties into the LV cavity.


The tracking process and conversion to Lagrangian ϵ was performed offline using dedicated software (EchoPAC; GE Vingmed Ultrasound AS).


Although this software was validated for the measurement of LV ϵ, it has been previously used for measuring LA ϵ with high feasibility and good agreement in many studies.


Follow-Up


Serial prospective follow-up (4 years) was obtained in all patients by means of a physician-directed telephone interview using a standardized questionnaire. The physicians were blinded to patient echocardiographic results. Hospitalization for cardiac cause was confirmed by review of hospital medical record. All patients were interviewed at least every 3 months during the follow-up period. After inclusion, all patients were seen every 6 months at an outpatient clinic and at any time they reported symptoms. At each examination, standard 12-lead ECG was used, and an inquiry was made about symptoms. A 24-hour Holter recording was made every month and at any time the patient had any symptoms suggesting AF.


The end point of the study was the occurrence of AF on standard 12-lead ECG or on 24-hour Holter recording.


Statistical Analysis


All analyses were performed using SPSS version 11.0 (SPSS, Inc., Chicago, IL). To compare patients with MS versus referents, or patients with MS with events versus those without events, unpaired Student’s t tests were used for continuous variables, while for categorical variables, Fisher’s exact tests were used. Quantitative values are presented as mean ± SD.


The relations between quantitative variables were studied using linear regression. In addition, a multivariate analysis was performed using forward stepwise Cox regression analysis using the likelihood ratio test, with a P value of .10 as the threshold for entering or removing variables. The multivariate analysis was elaborated from variables identified as statistically significant by univariate analysis and those considered clinically relevant.


In the search for a diagnostic cutoff value for the occurrence of events at follow-up, receiver operating characteristic curve analysis was performed, and the area under the curve is reported, which is representative of the discriminatory ability of the variable cutoff. Sensitivity and specificity and the positive and negative predictive values of the best cutoff variable were calculated.


P values < .05 were considered statistically significant.


The cumulative probability of freedom from AF was calculated using Kaplan-Meier life-table analysis and compared between groups using the log-rank test.


Interobserver variability, expressed as the coefficient of variation, was assessed by analyzing four longitudinal regions in 25 different, randomly chosen subjects by two independent investigators. For intraobserver variability, four longitudinal regions were analyzed by one investigator two times within an interval of 4 weeks. The second round of intraobserver measures was blinded to results from initial measures.




Results


General characteristics of the studied sample ( n = 101) are presented in Table 1 . Patients with MS showed LV dimensions and LV EFs comparable to those assessed in controls. LA width, LA volumes, and systolic pulmonary pressure were significantly increased in patients with MS.



Table 1

General characteristics of the studied sample













































































































Variable Patients with MS ( n = 101) Controls ( n = 70) P
Age (years) 51 ± 12 51 ± 12 >.90
Men/women 17/84 11/59 .84
BSA (m 2 ) 1.7 ± 0.2 1.7 ± 0.2 >.90
Heart rate (beats/min) 77 ± 17 76 ± 16 .70
Systolic blood pressure (mm Hg) 115 ± 10 114 ± 9 .50
Diastolic blood pressure (mm Hg) 73 ± 5 74 ± 6 .03
IVS end-diastolic thickness (mm) 9.8 ± 1.5 10 ± 1.5 .40
LV PW end-diastolic thickness (mm) 10 ± 2 10 ± 1 >.90
LV end-diastolic diameter (mm) 48 ± 6 48 ± 5 >.90
LV EF (%) 58 ± 4 58 ± 5 >.90
LA dimension (M-mode, anteroposterior) (mm) 49 ± 7 37 ± 2 <.0001
LA maximal volume (mL/m 2 ) 55 ± 26 22 ± 6 <.0001
LA minimal volume (mL/m 2 ) 36 ± 23 10 ± 4 <.0001
LA EF (%) 33 ± 19 45 ± 15 .0008
LA compliance index (%) 42 ± 22 93 ± 16 <.0001
Pulmonary arterial pressure (mm Hg) 37 ± 7 25 ± 6 <.0001
Average annular Ea (cm/sec) 5.1 ± 1.1 11.5 ± 4.3 .02
MVA by PHT (cm 2 ) 1.5 ± 0.4
MVA by 2D planimetry (cm 2 ) 1.5 ± 0.5
Mean gradient (mm Hg) 8 ± 5

BSA , Body surface area; IVS , interventricular septal; MVA , mitral valve area; PHT , pressure half-time; PW , posterior wall.

Data are expressed as mean ± SD or as numbers.


Atrial speckle-tracking data were obtained in all included patients. Atrial myocardial deformation indices (2D ϵ and SR) of the left atrium were significantly compromised in patients with MS ( Table 2 , Figures 1 and 2 ).



Table 2

Systolic myocardial deformation properties evaluated by 2D ϵ imaging study in patients with MS and controls




















































































Variable Patients with MS ( n = 101) Controls ( n = 70) P
Interatrial septum
ϵ (%) 16.5 ± 6.8 40.1 ± 7.2 <.0001
SR (sec −1 ) 0.72 ± 0.33 2.85 ± 0.65 <.0001
LA lateral wall
ϵ (%) 15.2 ± 4.2 38.3 ± 6.9 <.0001
SR (sec −1 ) 0.8 ± 0.24 2.51 ± 1.34 <.0001
LA inferior wall
ϵ (%) 15.6 ± 9.5 33.4 ± 7.3 <.0001
SR (sec −1 ) 0.82 ± 0.24 1.96 ± 0.53 <.0001
LA anterior wall
ϵ (%) 15 ± 8.6 34.7 ± 7.5 <.0001
SR (sec −1 ) 0.75 ± 0.2 2.18 ± 0.85 <.0001
LA average
ϵ (%) 15.2 ± 5.3 38.7 ± 6.6 <.0001
SR (sec −1 ) 0.82 ± 0.18 2.47 ± 0.55 <.0001

Data are expressed as mean ± SD.



Figure 1


LA deformation (ϵ) in a control. The peak systolic 2D ϵ average of the LA walls was 38.5 ± 6.4%.



Figure 2


LA deformation (ϵ) in a patient with MS. The peak systolic 2D ϵ average of the LA walls was 15.2 ± 5.2%.


LA width, volumes, and systolic pulmonary pressure were significantly increased ( P < .0001) and LA 2D ϵ and SR significantly compromised in patients with MS ( P < .0001).


In our results, no gender-based differences were found, and no significant correlations were found between LA 2D ϵ and SR and LA volumes, LA width, and LA EF.


After a 4-year follow-up period (mean follow-up duration, 52.5 ± 3.1 months), 20 patients (20%) showed paroxysmal ( n = 3) or persistent ( n = 17) AF on standard 12-lead ECG or at 24-hour Holter recording.


Comparing clinical characteristics of the patients with MS who had AF during the 4-year follow-up period with those who did not, the former were older, but no significant differences were found for LA dimensions, LA volumes, LA EF, and LA compliance index between patients with and without AF ( Table 3 ). LA myocardial systolic 2D ϵ was significantly impaired in patients with AF compared to those without AF during the 4-year follow-up period ( Table 4 ).



Table 3

Clinical and standard echocardiographic characteristics of patients with MS with arrhythmogenic events versus those without arrhythmogenic events during the 4-year follow-up period













































































































Variable Events ( n = 20) No events ( n = 81) P
Age (y) 57 ± 12 49 ± 11 .037
BSA (m 2 ) 1.7 ± 0.2 1.7 ± 0.2 >.90
Heart rate (beats/min) 76 ± 15 77 ± 14 .80
Systolic blood pressure (mm Hg) 114 ± 10 115 ± 15 .80
Diastolic blood pressure (mm Hg) 73 ± 4 72 ± 5 .53
MVA by 2D planimetry (cm 2 ) 1.36 ± 0.43 1.8 ± 0.4 .0007
MVA by PHT (cm 2 ) 1.46 ± 0.37 1.65 ± 0.5 .09
MV mean gradient 8 ± 5 8 ± 5 >.90
IVS end-diastolic thickness (mm) 9 ± 1 9 ± 2 >.90
LV PW end-diastolic thickness (mm) 9 ± 2 9 ± 2 >.90
LV end-diastolic diameter (mm) 46 ± 4 48 ± 7 .55
LV EF (%) 58 ± 4 58 ± 4 >.90
LA M-mode dimension (anteroposterior) (mm) 48 ± 7 47 ± 6 .555
LA dimension (longitudinal) (mm) 64 ± 11 62 ± 11 .52
LA dimension (transverse) (mm) 47 ± 9 47 ± 8 >.90
LA maximal volume (mL/m 2 ) 55 ± 29 53 ± 23 .78
LA minimal volume (mL/m 2 ) 36 ± 24 35 ± 22 .88
LA EF (%) 37 ± 20 36 ± 19 .86
LA compliance index 42 ± 16 49 ± 20 .199
Pulmonary arterial pressure (mm Hg) 34 ± 5 35 ± 5 .47

BSA , Body surface area; IVS , interventricular septal; MV , mitral valve; MVA , mitral valve area; PHT , pressure half-time; PW , posterior wall.

Data are expressed as mean ± SD or as numbers.


Table 4

Systolic myocardial deformation properties evaluated by 2D ϵ imaging study in patients with MS with arrhythmogenic events versus those without arrhythmogenic events during the 4-year follow-up period




















































































Variable Events ( n = 20) No events ( n = 81) P
Interatrial septum
ϵ (%) 14 ± 6 20 ± 7 .0038
SR (sec −1 ) 0.78 ± 0.3 1.1 ± 0.4 .024
LA lateral wall
ϵ (%) 13 ± 5 19 ± 7 .002
SR (sec −1 ) 0.91 ± 0.3 1 ± 0.3 .26
LA inferior wall
ϵ (%) 13 ± 5 19 ± 8 .006
SR (sec −1 ) 0.9 ± 0.4 1.2 ± 0.3 .002
LA anterior wall
ϵ (%) 14 ± 4 18 ± 6 .015
SR (sec −1 ) 1 ± 0.5 1.1 ± 0.4 .42
LA average
ϵ (%) 16 ± 5 21 ± 4 .0001
SR (sec −1 ) 0.93 ± 0.3 1 ± 0.3 .27

Only gold members can continue reading. Log In or Register to continue

Stay updated, free articles. Join our Telegram channel

Jun 2, 2018 | Posted by in CARDIOLOGY | Comments Off on Two-Dimensional Atrial Systolic Strain Imaging Predicts Atrial Fibrillation at 4-Year Follow-Up in Asymptomatic Rheumatic Mitral Stenosis

Full access? Get Clinical Tree

Get Clinical Tree app for offline access